David Branch Moody
NIH Rank #3853
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1899008Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$2.8M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#3,853
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing David Branch Moody as a PI. Multi-PI records show the full award amount for context.
- 4R01AI165573-04R01Chemical Biological Discovery of Lipid Virulence Factors in the Major Bacterial Pathogens$1.2Maward amount
- 5R37AR048632-24R37CD1 autoreactive T cells in human inflammatory skin disease$563.4Kaward amount
- 5R01AI049313-25R01T cell responses to CD1-restricted lipids in tuberculosis$450.3Kaward amount
- 3U19AI162584-05S1U19Metabolic determinants of Mtb virulence, vulnerability and variation$311.6Kaward amount
- 5U19AI162584-05U19Metabolic determinants of Mtb virulence, vulnerability and variation$290.9Kaward amount
Award organization
Organizations that administered FY2025 awards listing David Branch Moody as a PI.
FY2025 award administered by Brigham and Women's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBrigham and Women's Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5363
- 2025$2M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #3853
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as David Branch Moody.